Beyond Aduhelm: OIG Review Will Put FDA’s Entire Accelerated Approval Program Under Microscope

 
• By Sarah Karlin-Smith
FDA under OIG microscope (design by Nielsen Hobbs)
HHS OIG announced on 4 August a broad review of FDA's accelerated approval program • Source: Nielsen Hobbs

More from US FDA

More from Agency Leadership